𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacological treatment of disruptive behavior in Smith–Magenis syndrome

✍ Scribed by Gonzalo Laje; Rebecca Bernert; Rebecca Morse; Maryland Pao; Ann C.M. Smith

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
81 KB
Volume
154C
Category
Article
ISSN
1552-4868

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Behavioral phenotype of smith-magenis sy
Behavioral phenotype of smith-magenis syndrome (del 17p11.2)
✍ Smith, Ann C.M.; Dykens, Elizabeth; Greenberg, Frank 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 1 views

## Smith -Magenis syndrome (SMS) is a distinct and clinically recognizable multiple congenital anomaly (MCA) and mental retardation syndrome caused by an interstitial deletion of chromosome l7 p11.2. The phenotype of SMS has been well described and includes: a characteristic pattern of physical fe

Review of disrupted sleep patterns in Sm
Review of disrupted sleep patterns in Smith–Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion
✍ Eilis A. Boudreau; Kyle P. Johnson; Angela R. Jackman; Jan Blancato; Marjan Huiz 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB 👁 2 views

## Abstract Smith–Magenis syndrome (SMS) is a disorder characterized by multiple congenital anomalies and behavior problems, including abnormal sleep patterns. It is most commonly due to a 3.5 Mb interstitial deletion of chromosome 17 band p11.2. Secretion of melatonin, a hormone produced by the pi